Development and external validation of a prediction model for overall survi - Evidencio
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma
OBJECTIVE
To develop and validate a prediction model for 3-year overall survival after pancreatoduodenectomy for distal cholangiocarcinoma.

DESIGN
International cohort study.

MAIN OUTCOME MEASURE
3-year overall survival
Les auteurs de la recherche: Ali Belkouz, Stijn van Roessel, Marin Strijker, Jacob L. van Dam, Lois Daamen, Lydia G. van der Geest, Alberto Balduzzi, Andrea Benedetti Cacciaguerra, Susan van Dieren, Quintus Molenaar, Bas Groot Koerkamp, Joanne Verheij, Elizabeth van Eycken, Giuseppe Malleo, Mohammed Abu Hilal, Martijn G.H. van Oijen, Ivan Borbath, Chris Verslype, Cornelis J.A. Punt, Marc G. Besselink, Heinz-Jozef Klümpen, and Dutch Pancreatic Cancer Group
Version: 1.15
  • Public
  • Chirurgie
  • {{ modelType }}
  • Algorithme
  • Détails
  • Valider
  • Sauvegarder l'entrée
  • Entrée de la charge
  • {{ toolbarErrorMessage }}

Affichage
Unités

{{ section.title }}

{{ section.description }}

Calculer le résultat

Définir d'autres paramètres pour effectuer le calcul

3-Year overall survival probability

{{ resultSubheader }}
{{ $t('download_result_availability') }}
slide-left-right {{ $t('scroll_chart') }}
{{ chart.title }}
Intervalle de résultats {{ additionalResult.min }} à {{ additionalResult.max }}

Informations conditionnelles

Votre ou vos saisies ont été modifiées. Veuillez mettre à jour votre résultat. Mettre à jour

Background: Various prognostic factors are associated with overall survival (OS) after resection of distal cholangiocarcinoma (dCCA). The objective of this study was to develop and validate a prediction model for 3-year OS after pancreatoduodenectomy for dCCA.

Methods: The derivation cohort consisted of all patients who underwent pancreatoduodenectomy for dCCA in the Netherlands (2009-2016). Clinically relevant variables were selected based on the Akaike information criterion using a multivariate Cox proportional hazards regression model, with model performance being assessed by concordance index (C-index) and calibration plots. External validation was performed using patients from the Belgium Cancer Registry (2008-2016), and patients from two university hospitals of Southampton (U.K.) and Verona (Italy).

Results: Independent prognostic factors for OS in the derivation cohort of 454 patients after pancreatoduodenectomy for dCCA were age (HR 1.02, 95% CI 1.01-1.03), pT (HR 1.43, 95% CI 1.07-1.90) and pN category (pN1: HR 1.78, 95% CI 1.37-2.32; pN2: HR 2.21, 95% CI 1.63-3.01), resection margin status (HR 1.79, 95% CI 1.39-2.29) and tumour differentiation (HR 2.02, 95% CI 1.62-2.53). The prediction model was based on these prognostic factors. The optimism-adjusted C-indices were similar in the derivation cohort (0.69), and in the Belgian (0.66) and Southampton-Verona (0.68) validation cohorts. Calibration was accurate in the Belgian validation cohort (slope = 0.93, intercept = 0.12), but slightly less optimal in the Southampton-Verona validation cohort (slope = 0.88, intercept = 0.32). Based on this model, three risk groups with different prognoses were identified (3-year OS of 65.4%, 33.2% and 11.8%).

Conclusions: The prediction model for 3-year OS after resection of dCCA had reasonable performance in both the derivation and geographically external validation cohort. Calibration slightly differed between validation cohorts. The model is readily available via www. pancreascalculator.com to inform patients from Western European countries on their prognosis, and may be used to stratify patients for clinical trials.

{{ file.classification }}
PRO
Note
Les notes ne sont visibles que dans le téléchargement des résultats et ne sont pas sauvegardées par Evidencio.

Ce algorithme est fourni à des fins d'éducation, de formation et d'information. Il ne doit pas être utilisé pour aider à la prise de décision médicale ou pour fournir des services médicaux ou de diagnostic. Lire l'intégralité de notre disclaimer.

Algorithmes sous-jacents Une partie de
Commentaires
Commentaire
Veuillez saisir un commentaire
Les commentaires sont visibles par tous

Retour d'information sur le algorithme

Pas encore de retour d'information 1 Commentaire {{ model.comments.length }} Commentaires
Sur {{ comment.created_at }} {{ comment.user.username }} un auteur qui n'est plus enregistré a écrit :
{{ comment.content }}
logo

Veuillez vous connecter pour activer les fonctions d'impression d'Evidencio

Pour utiliser les fonctions d'impression d'Evidencio, vous devez être connecté.
Si vous n'avez pas de compte communautaire Evidencio, vous pouvez créer un compte personnel gratuit à:

https://www.evidencio.com/registration

Résultats imprimés - Exemples 2026-09-30 18:15


Avantages du compte communautaire Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Clause de non-responsabilité : les calculs ne doivent jamais dicter les soins aux patients et ne remplacent pas le jugement d'un professionnel.